MAZE
Maze Therapeutics, Inc.
36.73
+1.28 (+3.61%)
52w low 21.95
53.65 high
46.6% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | -30.05M | -24.64M | -27.73M | -39.11M | -15.05M | |
| Depreciation & Amort | -- | 649.00K | 571.00K | 499.00K | 444.00K | 391.00K | |
| Capital Expenditure | -- | -393.00K | -68.00K | -34.00K | -93.00K | -107.00K | |
| Free Cash Flow | -- | -30.45M | -24.71M | -27.76M | -39.21M | -15.16M | |
| Investing Cash Flow | -- | -393.00K | -66.88M | -103.39M | 6.28M | -128.51M | |
| Financing Cash Flow | -- | 612.00K | 143.76M | 3.59M | 42.36M | 147.44M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-100.0%